PDK4 and ovarian cancer: In ovarian cancer, the loss of FAM210B was found to reduce the expression of pyruvate dehydrogenase kinase 4 (PDK4) and glycolysis, promoting epithelial-to-mesenchymal transition (EMT), migration, and invasion [15].